Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Shanghai Menon Animal Nutrition Technology
301156
5
Nanjing Railway New Technology
301016
US Stock MarketDetailed Quotes
NTLA Intellia Therapeutics
- 6.630
- -0.260-3.77%
Close Apr 4 16:00 ET
- 6.590
- -0.040-0.60%
Post 20:01 ET
686.32MMarket Cap-1.26P/E (TTM)
6.910High6.430Low4.81MVolume6.830Open6.890Pre Close31.92MTurnover4.92%Turnover RatioLossP/E (Static)103.52MShares28.18052wk High0.79P/B649.16MFloat Cap6.43052wk Low--Dividend TTM97.91MShs Float202.730Historical High--Div YieldTTM6.97%Amplitude6.430Historical Low6.631Avg Price1Lot Size
About Intellia Therapeutics Company
Intellia Therapeutics, Inc. is a clinical stage genome editing company, which engages in the development of curative therapeutics using the CRISPR/Cas9 system. Its CRISPR/Cas9 system transforms medicine by both producing therapeutics that permanently edit and/or correct disease-associated genes in the human body with a single treatment course, and creates engineered cells that can treat oncological and immunological diseases. The company was founded by Andrew May, Luciano Marraffini, Rodolphe Barrangou, Nessan Bermingham, Rachel Haurwitz, Erik Sontheimer, Jennifer Doudna, and Derrick Rossi in May 2014 and is headquartered in Cambridge, MA.
Company Profile
SymbolNTLA
Company NameIntellia Therapeutics
Listing DateMay 6, 2016
Issue Price18.00
Founded2014
CEODr. John M. Leonard, M.D.
MarketNASDAQ
Employees403
Fiscal Year Ends12-31
Address40 Erie Street,Suite 130
CityCambridge
ProvinceMassachusetts
CountryUnited States of America
Zip Code02139
Phone1-857-285-6200
Websitehttp://www.intelliatx.com
Company Executives
- Name
- Position
- Salary
- Dr. John M. Leonard, M.D.
- Director, President and Chief Executive Officer
- 11.66M
- Eliana Clark
- Executive Vice President and Chief Technology Officer
- --
- Derek Hicks
- Executive Vice President and Chief Business Officer
- --
- Dr. David Lebwohl, M.D.
- Executive Vice President and Chief Medical Officer
- 4.26M
- Birgit Schultes
- Executive Vice President and Chief Scientific Officer
- --
- Michael P. Dube
- Vice President and Chief Accounting Officer
- --
- Edward J. Dulac, III
- Treasurer, Executive Vice President and Chief Financial Officer
- --
- James Basta, J.D.
- Executive Vice President, General Counsel and Corporate Secretary
- 3.99M
- Dr. Frank Verwiel, M.B.A.,M.D.
- Chairman of the Board
- 499.94K
- Muna Bhanji, Ph.
- Independent Director
- 455.25K
- William J. Chase
- Independent Director
- 996.21K
- Brian Goff
- Independent Director
- --
- Dr. Jesse Goodman, M.D.,M.P.H.
- Independent Director
- 449.94K
- Dr. Georgia Keresty, M.P.H.,PhD
- Independent Director
- 454.94K
- Dr. Fred E. Cohen, D.Phil.,F.A.C.P.,M.D.
- Independent Director
- 452.44K
Market Insights
Discussing
Chinese stock earnings surge: Will profit sustain the rally?
1. Which sectors are likely to be market highlights this season? 2. With the government's emphasis on technological innovation and sustaina
Moomoo News Global
Mar 4 23:26
China's Two Sessions: Key Takeaways on Stock Price Movements Before and After the Meetings
Discussing
FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma
Moo Live
Mar 20 02:25
FOMC Press Conference, March 19, 2025
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now
Discussing
Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context,
Moo Live
Jan 23 16:54
MicroStrategy Q4 2024 earnings conference call